Related by context. All words. (Click for frequent words.) 68 papillary renal cell carcinoma 67 included exfoliative dermatitis 67 Autoantibodies 67 hemorrhagic cystitis 67 Cryptococcus neoformans 66 intravascular hemolysis 66 kidney urologic 66 haematologic 66 Ribavirin causes 66 Enterobacter cloacae 66 induce orthostatic hypotension 66 antiphospholipid antibodies 66 metastatic malignant 66 N Engl J 66 Atypical Hemolytic Uremic Syndrome 65 CP CPPS 65 deep venous thromboses 65 anaphylactic reactions bronchospasm 65 Thromboembolic 65 interleukin IL -# 65 methicillin susceptible Staphylococcus aureus 65 Leukopenia neutropenia 65 R Saizen R 65 myocardial infarction ventricular fibrillation 65 Mg Uk 65 essential thrombocythemia ET 65 Moraxella catarrhalis 65 tryptase 65 Polymorphisms 65 myeloperoxidase 65 headache abdominal pain 65 Hemorrhagic 65 CYP#A# substrate 65 J Am Coll 65 SGPT 65 Asymptomatic 65 C. trachomatis 65 colorectal carcinoma 65 CYP#A# CYP#D# 64 cytomegalovirus infection 64 angioneurotic edema 64 Intravenous immunoglobulin 64 Endometrial 64 fibrosarcoma 64 colorectal adenoma 64 Bacteremia 64 Hepatotoxicity 64 #:#-# [023] 64 Staphylococcus epidermidis 64 Escherichia coli Klebsiella pneumoniae 64 Cancer Incidence Mortality 64 bullous 64 del 5q MDS 64 gestational hypertension 64 #:#-# [031] 64 relapsed MM 64 candidemia 64 gastric carcinoma 64 CC genotype 64 nonmetastatic 64 leiomyomas 64 myelodysplastic myeloproliferative diseases 64 acute humoral rejection 64 neutropenia dehydration dyspnea 64 complement inhibitor eculizumab 64 FUSILEV enhances 64 Clusterin 64 Erythropoietic therapies may 64 gastric cardia 64 HIV HCV coinfected 64 cisplatin gemcitabine 64 apolipoprotein E4 64 ertapenem 64 hepatoma 64 Mg Usa 64 #-# Full Text 64 demonstrated antitumor activity 64 Refractory Hodgkin Lymphoma 64 lactate dehydrogenase 64 elevated transaminases 64 erythematosus 64 headache nasopharyngitis 64 Prognostic significance 64 Epstein Barr Virus EBV 64 hypophosphatemia 63 Clin Chem 63 cisplatin resistant 63 T1c 63 mediated inhibition 63 Febrile neutropenia 63 lichen planus 63 Free Full Text 63 hypovitaminosis D 63 Cardiol 63 interleukin IL -6 63 methylenetetrahydrofolate reductase 63 Nonalcoholic fatty liver 63 colorectum 63 Helicobacter pylori infection 63 humanized interleukin 6 63 HBeAg negative 63 nasopharyngitis headache 63 NMIBC 63 colorectal adenocarcinoma 63 hematopoietic cancers 63 Poordad 63 Infect Dis 63 prostate cancer CaP 63 HLA DRB1 * 63 Primary Hypercholesterolemia 63 K ras mutations 63 trimethoprim sulfamethoxazole 63 PLX STROKE targeting 63 experimental allergic encephalomyelitis 63 selective modulator 63 SSc 63 Kalantar Zadeh 63 cervicitis 63 inverse agonist 63 Chronic Hepatitis C 63 Antitumor 63 hypermethylated 63 prolonged QT interval 63 serum leptin 63 seropositivity 63 lymphomas leukemias 63 #:#-# [035] 63 idiopathic membranous nephropathy 63 Soft Tissue Sarcoma 63 diabetes dyslipidemia 63 nonnucleoside reverse transcriptase inhibitors 63 Vidaza ® 63 leucopenia 63 prostate carcinoma 63 Hematologic 63 Papillary 62 lactate dehydrogenase LDH 62 epithelial tumors 62 LRP5 62 Human papillomavirus 62 hypogonadotropic hypogonadism 62 sunitinib Sutent ® 62 Streptococcus agalactiae 62 H. influenzae 62 cTnI 62 vaginal candidiasis 62 Staphylococci 62 Serum concentrations 62 thrombocytopenic 62 Lymphocytic 62 hyperphenylalaninemia HPA due 62 Trichomonas vaginalis 62 ß blockers 62 inducible nitric oxide synthase 62 Adenomas 62 pyrexia mucositis sepsis febrile 62 Arch Neurol 62 enterococcal 62 Nocardia 62 Elacytarabine 62 BARACLUDE ® 62 J Clin 62 P. ovale 62 abacavir Ziagen 62 proctitis 62 receptor tyrosine kinase inhibitor 62 neutropenia thrombocytopenia 62 Elevated serum 62 Cytotoxic T 62 NS5B polymerase 62 Plasmodium ovale 62 Subclinical 62 Adenoviral 62 MTHFR 62 invasive lobular 62 Tasigna prolongs 62 ergot derivatives 62 Streptococcus pneumoniae Haemophilus influenzae 62 DRB1 * 62 CYT# potent vascular disrupting 62 J Am Soc 62 moderate hepatic impairment 62 TO AVOID PREGNANCY WHILE 62 Cancer Res 62 Antitumor Activity 62 See WARNINGS 62 MD MHSc 62 COX2 62 Teriflunomide 62 Progressive Multifocal Leukoencephalopathy 62 Epidermal Growth Factor Receptor 62 hip osteonecrosis avascular 62 pancreatic prostate 62 Entamoeba histolytica 62 ANCA associated 62 % CI #.#-#.# [007] 62 Hashimoto thyroiditis 62 Nosocomial 62 adriamycin 62 #:#-# [029] 62 fluconazole resistant 62 metastatic neuroendocrine tumors 62 fluoroquinolone resistance 62 Parnate 62 dasatinib Sprycel ® 62 Severe Sepsis 62 Leukemias 62 Squamous cell 62 FluCAM arm 62 Shows Promise Against 62 Postoperative complications 62 LHRH receptor positive 62 Renal Insufficiency 62 hematological parameters 62 Thiazolidinediones 62 glutamic acid decarboxylase 62 Chlamydia trachomatis infection 62 maternal serum 62 alanine aminotransferase 62 virus HBV 62 Phospholipase A2 62 impaired glucose metabolism 61 phenothiazines 61 pT3 61 node metastases 61 Acute Bacterial Sinusitis ABS 61 Fibroblast 61 Nat Rev 61 itraconazole Sporanox 61 J Am Acad 61 resistant Staphylococcus aureus MRSA 61 oseltamivir resistant 61 Immunotherapeutic 61 Orthostatic hypotension 61 Systemic lupus erythematosus 61 Leydig cell 61 N. gonorrhoeae 61 Systemic lupus erythematosus SLE 61 autonomic dysfunction 61 dominantly inherited 61 TNF Blockers 61 somatostatin analog 61 Multidrug resistant 61 carotid plaques 61 torsade de pointes 61 Bronchopulmonary Dysplasia 61 aminotransferase 61 chlamydial 61 #:#-# [028] 61 venous thromboembolic disease 61 Flu Cy 61 antiretroviral naïve 61 KRAS oncogene 61 Ann Oncol 61 Basal Cell 61 hypereosinophilic syndrome 61 Am J Obstet 61 Glucocorticoids 61 Enterococcus faecium 61 upregulates 61 leukocyte counts 61 transfusion syndrome 61 Prostatic 61 pulmonary metastasis 61 AVAPRO 61 Neurol 61 oral squamous cell 61 novel VDA molecule 61 G CSFs 61 discontinued Viread 61 autoimmune thyroid 61 coagulation abnormalities 61 erosive gastritis 61 non resectable metastatic 61 thyroid carcinoma 61 Oncogenic 61 IMiDs ® compound 61 TNF Tumor Necrosis Factor 61 tumor xenograft models 61 Staphyloccus aureus 61 AA Amyloidosis 61 histological subtype 61 basal cell carcinoma BCC 61 pancreas esophagus 61 Proc Natl Acad Sci 61 Catheter Associated 61 metastatic gastric 61 Hepatocellular Carcinoma HCC 61 ADPKD 61 NIDDM 61 Non Alcoholic Fatty 61 nasal carriage 61 AML MDS 61 polycythemia vera essential thrombocythemia 61 Trichophyton rubrum 61 oxacillin 61 adrenomedullin 61 Eur J Endocrinol 61 HBeAg 61 recurrent venous thromboembolism 61 Cathepsin B 61 pseudomembranous colitis 61 abdominal adiposity 61 BRAF V#E 61 metastatic colorectal 61 Nephrol 61 IPAH 61 hamartomas 61 rs# [002] 61 thalidomide Thalomid 61 Mycoplasma pneumoniae 61 Inactivation 61 malignant neoplasm 61 PAOD 61 Bronchiolitis 61 ovarian carcinoma 61 Immunohistochemical staining 61 ALT normalization 61 Myelodysplastic Syndrome MDS 61 Moxifloxacin 61 thrombophilia 61 Erythema 61 intraventricular hemorrhage 61 Intracerebral 61 atherosclerotic vascular disease 61 Commonly prescribed 61 resistant hormone refractory 61 zoledronate 61 indinavir Crixivan 61 invasive carcinomas 61 lipoprotein Lp 61 GSTT1 61 pathophysiological effects 61 quetiapine Seroquel 61 recurrent metastatic 61 methicillin susceptible 61 somnolence dizziness 61 Am J Cardiol 61 Malignancies 61 liposomal amphotericin B 61 mediastinitis 61 gefitinib Iressa 61 rs# [004] 61 chloride secretion 61 Adjuvant Chemotherapy 61 bladder ovarian 61 Nilotinib 61 #:#-# [024] 61 TCF#L# gene 61 Arch Intern Med 61 K. pneumoniae 61 clomipramine 61 linezolid resistant 61 primary hyperparathyroidism 61 ovarian pancreatic 61 localized prostate 60 Varicella zoster virus 60 irreversible inhibitor 60 breast endometrial 60 Cytomegalovirus 60 carbapenem resistant 60 Carcinomas 60 Dermatol 60 COPEGUS R 60 sotalol 60 HepG2 cells 60 cause cardiac channelopathies 60 thromboxane A2 60 myocardial ischaemia 60 PEGylated anti 60 bronchoalveolar lavage 60 trophoblastic 60 SGOT 60 Hyperkalemia 60 BRSV 60 isoenzyme 60 malignant ovarian 60 lymphocytosis 60 eosinophil count 60 Int J Radiat Oncol 60 metastatic GIST 60 chronic renal disease 60 invasive ductal 60 severe neutropenia 60 nonhematologic adverse reactions 60 Chlamydia pneumoniae 60 #:#-# [033] 60 J Clin Oncol 60 fluoroquinolone resistant 60 arterial thromboembolic 60 lymphadenopathy 60 cholangiocarcinoma 60 Kinoid 60 atrophic gastritis 60 unstable angina pectoris 60 Upregulation 60 orchitis 60 PR interval prolongation 60 chlamydial infections 60 receptor inhibitor 60 Candida infection 60 inversely associated 60 steroidogenic 60 ALB # 60 5 HT2A inverse 60 Clostridium perfringens 60 immunopathology 60 Myeloid 60 surgically resected 60 chronic eosinophilic leukemia 60 surgically resectable 60 paragangliomas 60 glutamyl 60 GG genotype 60 dopamine D2 60 Hematopoietic 60 oesophageal adenocarcinoma 60 See CLINICAL PHARMACOLOGY 60 Myocarditis 60 Kahalalide F 60 atrophic vaginitis 60 Atherosclerotic 60 Preclinical Study 60 herpes zoster shingles 60 hyperhomocysteinemia 60 Unstable Angina 60 transferrin saturation 60 bacterium Mycobacterium tuberculosis 60 Trypanosoma cruzi 60 pyogenes 60 benign uterine 60 transaminase elevations 60 NSAID induced GI 60 J Foot Ankle 60 Myelodysplastic Syndrome 60 Cancer J Clin 60 bacterium Neisseria meningitidis 60 Thrombotic 60 alfuzosin 60 abacavir lamivudine 60 TIMP 1 60 urothelial carcinoma 60 Non Alcoholic Steatohepatitis 60 antiplatelet medications 60 epididymitis 60 pulmonary alveolar 60 null responder 60 Sclerosing 60 Arrhythmogenic 60 COL#A# 60 N. Engl 60 atherosclerotic CVD 60 Complicated Skin 60 primidone 60 griseofulvin 60 Am J Clin 60 non mutated KRAS 60 BMPR2 60 underlying vasculopathy 60 Clinical Outcome 60 assay detects 60 myeloproliferative neoplasms 60 J Clin Endocrinol Metab 60 Exacerbation 60 selectively inhibited 60 cyclophosphamide methotrexate 60 Methicillin resistant S. aureus 60 methicillin resistant S. aureus 60 2 methoxyestradiol 60 MYH9 gene 60 nonbacterial 60 gastric carcinogenesis 60 papillary carcinoma 60 Respiratory Syncytial Virus RSV 60 Serologic 60 Novel Oral 60 Acute Exacerbations 60 J Allergy Clin 60 recurrent acute pancreatitis 60 paraneoplastic 60 Hemodialysis Patients 60 necrotizing 60 Drug Prevents 60 B7 H3 60 serum estradiol 60 immunocompetent patients 60 HLA DR4 60 #beta 60 Candidiasis 60 EGFR mutation positive 60 Pneumocystis carinii pneumonia 60 mild renal insufficiency 60 Myocardial infarction 60 bronchoalveolar 60 arterial calcification 60 Cytomegalovirus CMV 60 Salmonella Shigella 60 syngeneic 60 ileocecal 60 situ CIS 60 Monoclonal 60 ovarian carcinomas 60 Infect Control 60 Prevalence Worldwide 60 chromosome #p# [002] 60 Aeromonas 60 thetreatment 60 Eur Urol 60 Janus kinase 60 Acute Liver Failure 60 urogenital infections 60 Microalbuminuria 60 virus XMRV 60 antinuclear antibodies 60 J Pediatr 60 E. faecalis 60 BERKELEY CA UroToday.com 60 urticaria hives 60 amebiasis 60 NASH Huntington 60 Adjuvant chemotherapy 60 coinfection 60 cholelithiasis 60 gonococcal 60 microbiologically evaluable 60 immunocompetent 60 prospectively evaluated 59 myelofibrosis polycythemia vera 59 multivariate adjustment 59 neoplasias 59 monogenic 59 biologic DMARD 59 Di Bisceglie 59 pheochromocytoma 59 pancreatic adenocarcinoma 59 recurrent glioblastoma multiforme 59 Meta Analysis 59 #:#-# [037] 59 perioperatively 59 BRCA1 BRCA2 59 fatigue diarrhea nausea 59 intracellular accumulation 59 Pulmonary embolism 59 Histologic 59 Endocarditis 59 bacillus Calmette Guerin 59 penicillin resistant Streptococcus 59 S. aureus isolates 59 Verstovsek 59 biochemical relapse 59 hyperlipidemic 59 predisposing factor 59 hepatic lipase 59 antibody titer 59 Cell Proliferation 59 5 HT6 receptor 59 soluble tumor necrosis 59 finasteride Proscar 59 invasive candidiasis 59 Crit Rev 59 Clin Oncol 59 BI/NAP#/# 59 Linezolid 59 Allogeneic 59 Cardiotoxicity 59 Nat Genet 59 Herpes zoster 59 evaluating tivozanib 59 quinolone resistant 59 IDDM 59 Oxidized LDL 59 Plasmodium vivax 59 IgM antibodies 59 cardiac troponin T 59 convulsive disorders 59 TT genotype 59 Crit Care Med 59 bacterial vaginosis BV 59 tachyarrhythmias 59 Hormone Refractory Prostate Cancer 59 HLA DR2 59 intracranial atherosclerosis 59 cSSSIs 59 HLA DR4 immune 59 endometrial hyperplasia 59 Osteopontin 59 HBeAg negative patients 59 Enterobacter 59 5 HT2A serotonin 59 protein tyrosine phosphatase 1B 59 cerebral vasospasm 59 CagA 59 deoxy 59 Phase 2b Clinical Trial 59 LymphoStat B belimumab 59 D aspartate NMDA receptor 59 neurological manifestations 59 bacteriuria 59 headache nausea fatigue 59 patientswith 59 Chlamydophila pneumoniae 59 Subgroup analysis 59 renal failure interstitial lung 59 Cutaneous 59 Genetic Variation 59 NSAID associated 59 haemolytic 59 DMSc 59 post transplant lymphoproliferative 59 SNP rs# [001] 59 aplastic anemia AA 59 LPS induced 59 Maven Semantic 59 Antihypertensive 59 ALT elevation 59 acid phosphatase PAP 59 Pneumocystis 59 lipid elevations 59 vancomycin resistant 59 Magnesium deficiency 59 Omacetaxine 59 PTPN# 59 thrombophlebitis 59 Eculizumab 59 COPEGUS therapy 59 UGT#A# * 59 bacteria Neisseria meningitidis 59 ACC2 59 genus Plasmodium 59 capillary leak 59 NAT2 59 refractory chronic lymphocytic 59 thromboembolic disease 59 fulminant hepatic failure 59 Oral Fingolimod 59 Lipid Metabolism 59 Lactobacillus reuteri 59 parathyroid carcinoma 59 β blockers 59 chronically immunosuppressed solid 59 Chronic lymphocytic leukemia 59 amnestic 59 Septicemia 59 Prostatitis 59 de novo coronary artery 59 J Nutr 59 neutrophil counts 59 TNF blocker therapy 59 overt hepatic encephalopathy HE 59 Chlamydia psittaci 59 Plasma concentrations 59 tetracycline antibiotic 59 Squamous 59 nontuberculous mycobacteria 59 papillary thyroid carcinoma 59 intestinal metaplasia 59 interferon beta 1a infertility 59 vinca alkaloid 59 gonococcal infections 59 FLT3 ITD 59 serum triglycerides 59 Salmonella typhi 59 ABCB1 59 nasopharyngeal carcinoma 59 TEAEs 59 diabetes mellitus DM 59 Bordetella pertussis 59 mTOR mammalian target 59 Paroxysmal Nocturnal Hemoglobinuria 59 Propionibacterium 59 lupus erythematosus 59 Prolongs Survival 59 pneumocystis pneumonia 59 dasatinib Sprycel 59 Adenoma 59 HBsAg positive 59 Hematological 59 HeFH 59 IMiDs R 59 Opportunistic infections 59 colon carcinoma 59 #p# [003] 59 Selective Inhibitor 59 coronary artery atherosclerosis 59 Van Cutsem E 59 Hyperlipidemia 59 ASCUS 59 venous malformations 59 thyrotropin 59 neuroinflammatory 59 â ‰ ¥ 59 HMG CoA reductase inhibitors 59 CYP #D# 59 PON1 activity 59 shorter telomere length 59 Uncontrolled hypertension 59 Hypertriglyceridemia 59 events thrombocytopenia neutropenia 59 Venous Thromboembolism 59 immunoreactivity 59 H. pylori infections 59 eradicate H. pylori 59 Flavivirus 59 advanced hepatocellular carcinoma 59 #:#-# [020] 59 DU# [002] 59 GPC5 59 salmeterol HFA MDI 59 leukemia multiple myeloma 59 Hepatitis B Virus 59 Lymphoid 59 Am J Respir 59 TIMI Study Group 59 Renal Impairment 59 CIN2 + 59 gastric adenocarcinoma 59 Chronic pancreatitis 59 grade squamous intraepithelial 59 cytolytic 59 alanine aminotransferase ALT 59 sulfamethoxazole 59 Treponema 59 methicillin sensitive 59 TRAIL R1 59 IMiDs ® 59 Monica Mita 59 Tyrosine Kinase Inhibitor 59 transaminase 59 osteosarcomas 59 HNSCC 59 proximal colon 59 histologic subtype 59 Endocrinol 59 μg liter 59 unresectable tumors 59 indinavir 59 Peripheral Arterial 59 genital ulcers 59 colorectal neoplasms 59 uterine cervix 59 atherothrombotic 59 ANN INTERN MED 59 Randomized Double blind 59 Chronic Prostatitis 59 Zeuzem 59 triiodothyronine 59 pT2 59 Bice WS Jurkovic I. 59 Inhibin B 59 urethritis 59 vivax 59 constitutively expressed 59 Legg Calvé Perthes disease 59 T#I [002] 59 allogeneic hematopoietic cell 59 Estrogen Receptor 59 postoperative delirium 59 Comorbid 59 malignant prostate 59 Vascugel 59 ESBL producing 59 Anti Tumor 59 Soc Sci Med 59 acadesine 59 varicella zoster virus VZV 59 Pegylated 59 1alpha 59 Streptococcus pyogenes 59 osteoid osteoma 59 atypical Hemolytic Uremic Syndrome 59 Eur J 59 gastrointestinal stromal 59 replicon 59 advanced adenoma 59 antiangiogenic therapy 59 inhibiting COX 59 CLINICAL PHARMACOLOGY 59 Heterozygous 59 confidence interval #.#-#.# 59 genetic polymorphism 59 Renata Pasqualini 59 CYP #A# 59 fosbretabulin 59 Demonstrates Sustained 59 erlotinib Tarceva ® 58 tumor regressions 58 J Urol 58 Am J Epidemiol 58 TRAIL R2 58 Chronic Hepatitis 58 recurrent UTI 58 Polymerase Inhibitor 58 multicentric 58 ADRB2 58 beta carotene supplementation 58 Doxil ® 58 MGd 58 doi #.#/S#-# 58 E. histolytica 58 serum aminotransferase levels 58 busulfan 58 Antiviral Therapy 58 hemorrhagic cerebrovascular events 58 KIF6 gene 58 gene polymorphism 58 Chlamydia gonorrhea 58 Posttraumatic stress disorder 58 subcutaneous immunoglobulin 58 eosinophilia 58 thyroid peroxidase 58 atherothrombosis 58 Gleevec resistant 58 chromosome #p#.# 58 Idiopathic Pulmonary Fibrosis 58 BEXXAR Therapeutic Regimen 58 Antibiotic resistant 58 hypothalamic pituitary 58 Environ Health Perspect 58 Pelvic Inflammatory Disease 58 nonhereditary 58 pyelonephritis 58 membranous nephritis 58 cirrhosis liver failure 58 Peptide YY 58 angiotensin receptor blockers ARB 58 e antigen HBeAg 58 papular 58 #q# deletion syndrome 58 Haemophilus influenzae Moraxella catarrhalis 58 haematopoietic 58 Arteriosclerosis 58 serum IGF 58 BRAF V#E mutation 58 vWD 58 Adiposity 58 Osteoporos Int 58 Visceral leishmaniasis 58 Parkin DM 58 Anesth 58 Chlamydia trachomatis 58 Relapsing Multiple Sclerosis 58 Bullous 58 Excretion 58 prolactin elevation 58 glycopeptide 58 Uterine 58 Patency 58 Nutr 58 endometriosis ovarian cysts 58 induced mucositis 58 Skeletal Muscle 58 intraepithelial neoplasia 58 metaplasia 58 HCV Hepatitis C 58 germline mutations 58 By Peggy Bresnick 58 peritoneal carcinomatosis 58 Alkaline Phosphatase 58 serum homocysteine 58 Patrick Serruys 58 Daptomycin 58 androgen receptor AR 58 reduce serum phosphate 58 Babesia 58 TNFalpha 58 seminoma 58 prostate carcinogenesis 58 LNCaP cells 58 systemic mastocytosis 58 epithelial ovarian 58 Macrophage 58 elevated fasting glucose 58 obstructive coronary 58 metastatic pancreatic 58 gene polymorphisms 58 receiving immunosuppressive therapy 58 HLA DRB1 58 L. pneumophila 58 Immune Responses 58 CDKN2A 58 homocysteine concentrations 58 bronchogenic carcinoma 58 stage IIIB 58 smoldering myeloma 58 nephrotoxicity 58 tumoral 58 Contraindications 58 MLH1 58 irinotecan doxorubicin oxaliplatin paclitaxel 58 bacterium Streptococcus 58 Interferon gamma 58 imatinib therapy 58 Obstet Gynecol 58 S aureus 58 XL# inhibits 58 scombroid poisoning 58 von Hippel Lindau 58 pCR 58 tumors GIST 58 neoadjuvant treatment 58 sunitinib Sutent 58 ALN HPN 58 Non inferiority 58 parasitaemia 58 Factor Receptor 58 Eprodisate 58 Antigen Specific 58 unstable angina UA 58 pulmonary thromboembolism 58 Enterococci 58 Castration Resistant Prostate Cancer 58 graft occlusion 58 ductal carcinomas 58 polymyxin B 58 oral thrush 58 selective antagonist 58 bexarotene 58 Prophylactic Treatment 58 subclinical disease 58 nmol liter 58 Staphylococcal 58 Bacterial Vaginosis 58 intravenous bisphosphonates 58 nonsteroidal antiinflammatory drugs 58 telomerase inhibition 58 Tardive dyskinesia 58 Zinc deficiency 58 lymphoproliferative disorders 58 serogroup B 58 Prognostic Factors 58 refractory NSCLC 58 adiponectin concentrations 58 S. Aureus 58 Salmonella spp 58 bioavailable testosterone 58 serotype #A 58 Darapladib 58 Interstitial cystitis 58 Kantarjian 58 lymphopenia 58 vulvovaginal candidiasis 58 mycotic 58 Chronic Myelogenous Leukemia 58 serum GGT 58 Trichophyton 58 Mild hypothermia 58 #OHD levels 58 hepatic dysfunction 58 imipramine Tofranil 58 J Shoulder Elbow 58 Pseudomonas aeruginosa infections 58 Leydig cells 58 Ann Intern Med 58 SinuNase ™ 58 neutrophil elastase 58 deCODE AF TM 58 Hurthle cell 58 Polycythemia vera 58 GSTP1 58 simplex virus 58 tissue transglutaminase 58 KRAS mutant tumors 58 atopic asthma 58 experimental autoimmune encephalomyelitis 58 silent ischemia 58 Citrobacter 58 Triapine R 58 nodal metastasis 58 AMACR 58 Streptococcus pneumonia 58 non cirrhotic portal 58 pneumoniae PRSP 58 FASEB J. 58 EEG abnormalities 58 perianal 58 receiving chemoradiation therapy 58 hormone refractory metastatic prostate 58 catechol O methyltransferase 58 #:#-# [007] 58 Angiotensin converting enzyme 58 endometrial carcinoma 58 Diabetic Foot Ulcer 58 Invasive Breast Cancer 58 multivariate Cox 58 Anaplasma 58 NS#/#A protease 58 carcinoembryonic antigen 58 fallopian tube carcinoma 58 Corynebacterium 58 polyp recurrence 58 ankylosing spondylitis AS 58 rheumatoid arthritis systemic lupus 58 Michael F. Leitzmann 58 hyperplasia BPH 58 dysplastic lesions caused 58 Anders Hviid 58 TMEM#B 58 paclitaxel cisplatin 58 antiandrogen